Michael Schmid

Papers

Total Citations

H-Index

About

Dr. Michael Schmid is a virologist whose work focuses on the development of innovative tools to combat mosquito-borne flaviviruses, particularly dengue virus. His most cited research introduces a high-content imaging-based assay using a dengue virus type 2 reporter expressing the fluorescent protein mCherry (DV2/mCherry). This breakthrough, published in 2020 and garnering 21 citations, enables rapid, high-throughput screening for antiviral compounds—a critical step given that nearly half the world’s population is at risk and no specific prophylaxis exists. By creating a robust, quantifiable system to monitor viral replication in real time, Schmid’s assay accelerates the discovery of potent anti-dengue drugs. His work bridges the gap between basic virology and translational drug development, offering a scalable platform that can be adapted for other flaviviruses. For students and researchers, Schmid’s contributions exemplify how creative assay design can directly address urgent global health threats, making him a key figure in the fight against emerging viral diseases.